218 related articles for article (PubMed ID: 19913617)
41. Fasudil, a Rho-Associated Protein Kinase Inhibitor, Attenuates Traumatic Retinal Nerve Injury in Rabbits.
Yu J; Luan X; Lan S; Yan B; Maier A
J Mol Neurosci; 2016 Jan; 58(1):74-82. PubMed ID: 26635024
[TBL] [Abstract][Full Text] [Related]
42. Fasudil suppresses fibrosarcoma growth by stimulating secretion of the chemokine CXCL14/BRAK.
Miyamoto C; Maehata Y; Ozawa S; Ikoma T; Kubota E; Izukuri K; Kato Y; Hata R; Lee MC
J Pharmacol Sci; 2012; 120(3):241-9. PubMed ID: 23099322
[TBL] [Abstract][Full Text] [Related]
43. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
[TBL] [Abstract][Full Text] [Related]
44. Fasudil protects cultured N1E-115 cells against lysophosphatidic acid-induced neurite retraction through inhibition of Rho-kinase.
Satoh S; Kawasaki K; Hitomi A; Ikegaki I; Asano T
Brain Res Bull; 2011 Feb; 84(2):174-7. PubMed ID: 21126559
[TBL] [Abstract][Full Text] [Related]
45. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
[TBL] [Abstract][Full Text] [Related]
46. Effects of Rho-kinase inactivation on eosinophilia and hyper-reactivity in murine airways by allergen challenges.
Taki F; Kume H; Kobayashi T; Ohta H; Aratake H; Shimokata K
Clin Exp Allergy; 2007 Apr; 37(4):599-607. PubMed ID: 17430358
[TBL] [Abstract][Full Text] [Related]
47. Rho Kinase Inhibitor Fasudil Suppresses the Vasculogenic Mimicry of B16 Mouse Melanoma Cells Both In Vitro and In Vivo.
Xia Y; Cai XY; Fan JQ; Zhang LL; Ren JH; Chen J; Li ZY; Zhang RG; Zhu F; Wu G
Mol Cancer Ther; 2015 Jul; 14(7):1582-90. PubMed ID: 25934709
[TBL] [Abstract][Full Text] [Related]
48. Impacts of Rho kinase inhibitor Fasudil on Rho/ROCK signaling pathway in rabbits with optic nerve injury.
Yu J; Lin L; Luan X; Jing X; Maierab
Int J Clin Exp Pathol; 2015; 8(11):14717-24. PubMed ID: 26823796
[TBL] [Abstract][Full Text] [Related]
49. Fasudil ameliorates the ischemia/reperfusion oxidative injury in rat hearts through suppression of myosin regulatory light chain/NADPH oxidase 2 pathway.
Zhang YS; Tang LJ; Tu H; Wang SJ; Liu B; Zhang XJ; Li NS; Luo XJ; Peng J
Eur J Pharmacol; 2018 Mar; 822():1-12. PubMed ID: 29337194
[TBL] [Abstract][Full Text] [Related]
50. Rho Kinase Inhibition Is Essential During In Vitro Neurogenesis and Promotes Phenotypic Rescue of Human Induced Pluripotent Stem Cell-Derived Neurons With Oligophrenin-1 Loss of Function.
Compagnucci C; Barresi S; Petrini S; Billuart P; Piccini G; Chiurazzi P; Alfieri P; Bertini E; Zanni G
Stem Cells Transl Med; 2016 Jul; 5(7):860-9. PubMed ID: 27160703
[TBL] [Abstract][Full Text] [Related]
51. Protective effect of a novel Rho kinase inhibitor WAR-5 in experimental autoimmune encephalomyelitis by modulating inflammatory response and neurotrophic factors.
Li YH; Yu JZ; Xin YL; Feng L; Chai Z; Liu JC; Zhang HZ; Zhang GX; Xiao BG; Ma CG
Exp Mol Pathol; 2015 Oct; 99(2):220-8. PubMed ID: 26112093
[TBL] [Abstract][Full Text] [Related]
52. RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis.
Bei Y; Hua-Huy T; Nicco C; Duong-Quy S; Le-Dong NN; Tiev KP; Chéreau C; Batteux F; Dinh-Xuan AT
Exp Lung Res; 2016; 42(1):44-55. PubMed ID: 26873329
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection.
Rikitake Y; Kim HH; Huang Z; Seto M; Yano K; Asano T; Moskowitz MA; Liao JK
Stroke; 2005 Oct; 36(10):2251-7. PubMed ID: 16141422
[TBL] [Abstract][Full Text] [Related]
54. RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations.
Shenkar R; Shi C; Austin C; Moore T; Lightle R; Cao Y; Zhang L; Wu M; Zeineddine HA; Girard R; McDonald DA; Rorrer A; Gallione C; Pytel P; Liao JK; Marchuk DA; Awad IA
Stroke; 2017 Jan; 48(1):187-194. PubMed ID: 27879448
[TBL] [Abstract][Full Text] [Related]
55. Rho kinase inhibition by fasudil exerts antioxidant effects in hypercholesterolemic rats.
Ma Z; Zhang J; Ji E; Cao G; Li G; Chu L
Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):688-94. PubMed ID: 21711379
[TBL] [Abstract][Full Text] [Related]
56. Changes of synapses in experimental autoimmune encephalomyelitis by using Fasudil.
Yu JZ; Chen C; Zhang Q; Zhao YF; Feng L; Zhang HF; Meng J; Ma CG; Xiao BG
Wound Repair Regen; 2016 Mar; 24(2):317-27. PubMed ID: 26789651
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of intracellular Ca2+ release by a Rho-kinase inhibitor for the treatment of ischemic damage in primary cultured rat hippocampal neurons.
Huang L; Li Q; Li H; He Z; Cheng Z; Chen J; Guo L
Eur J Pharmacol; 2009 Jan; 602(2-3):238-44. PubMed ID: 19070614
[TBL] [Abstract][Full Text] [Related]
58. Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders?
Chen M; Liu A; Ouyang Y; Huang Y; Chao X; Pi R
Expert Opin Investig Drugs; 2013 Apr; 22(4):537-50. PubMed ID: 23461757
[TBL] [Abstract][Full Text] [Related]
59. Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells.
Ogata S; Morishige K; Sawada K; Hashimoto K; Mabuchi S; Kawase C; Ooyagi C; Sakata M; Kimura T
Int J Gynecol Cancer; 2009 Dec; 19(9):1473-80. PubMed ID: 19955921
[TBL] [Abstract][Full Text] [Related]
60. Systemic Rho-kinase inhibition using fasudil in mice with oxygen-induced retinopathy.
Brockmann C; Corkhill C; Jaroslawska E; Dege S; Brockmann T; Kociok N; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1699-1708. PubMed ID: 31152312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
